CEACAM5 and ovarian carcinoma: Several approaches that fit these criteria have been proposed to combat the shortcomings of the current techniques, including the use of other tumor markers such as CA-15-3 and carcinoembryonic antigen (CEA) which are both elevated in patients with ovarian cancer [44].